SECOND OPINION: LAETRILE AT SLOAN-KETTERING

Cinemavixion Review

"Second Opinion: Laetrile at Sloan-Kettering" emerges as a compelling, albeit controversial, documentary that delves into a deeply sensitive subject: the potential of non-conventional cancer therapies and the alleged suppression of their success. Director Eric Merola presents a narrative centered on a whistleblower's account within a prominent cancer research institution, suggesting a deliberate cover-up of positive results concerning Laetrile. The film, supported by documents and archival footage, aims to expose a systemic failure to explore alternative treatments. While the film garnered a mixed reception, with Rotten Tomatoes indicating a divided critical consensus and a Metacritic score suggesting a more critical view, its IMDb rating points to a significant audience appreciation for its investigative approach. This documentary is a must-watch for those interested in the complex intersection of medicine, ethics, and institutional power, prompting viewers to question established narratives in the fight against cancer.